Compare Altria Group Inc (MO) vs 10X Genomics Inc (TXG) Price & Performance

Altria Group IncTrade

10X Genomics IncTrade

Price performance (Past 24H)

Key statistics

Altria Group Inc vs 10X Genomics Inc — how do they compare? Altria Group Inc trades at $73.25 (market cap $124.67B), while 10X Genomics Inc trades at $46.82 (market cap $5.48B). The key difference: Altria Group Inc is far larger — about 22.8× 10X Genomics Inc's market cap, and Altria Group Inc pays a 5.68% dividend while 10X Genomics Inc pays none. Which is the better fit depends on your goals.

	MO	TXG
Market Cap	$124.67B	$5.48B
Sector	Consumer Staples	Health
52-Week High	$74.66	$45.80
52-Week Low	$54.72	$11.34
Enterprise Value	$145.75B	$5.02B
Dividend Yield	5.68%	—

View details →View details →

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

Dividend Harvesting Portfolio tops $40K with 43.6% return, focusing on growing income and tech sector bets.Seeking Alpha · 1 day agoBullish SPYI ETF yields 12% but faces pressure as volatility drops and Treasury yields rise.24/7 Wall Street · 4 days agoNeutral View details →

TXG

New report details 1,230+ bioinformatics deals, revealing market trends and deal structures through 2026Researchandmarkets.Com · 4 days agoNeutral View details →

About Altria Group Inc

Altria comprises Philip Morris USA, U.S. Smokeless Tobacco, John Middleton, Helix Innovations, and Philip Morris Capital, although the company plans to wind down Philip Morris Capital by the end of 2022. It holds a 10% interest in the world's largest brewer, Anheuser-Busch InBev. Through its tobacco subsidiaries, Altria holds the leading position in cigarettes and smokeless tobacco in the United States and the number-two spot in machine-made cigars. The company's Marlboro brand is the leading cigarette brand in the U.S. with a 43% share in 2020. Altria holds strategic investments in JUUL Labs (35% economic interest) and Cronos (42%).

About 10X Genomics Inc

10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The product portfolio of the company includes Chromium Controller, Reagent Kits, 10x Compatible Products, and Informatics Software among others. The majority of its revenue is generated from consumables.